Misplaced obsession with prospectively randomized studies

Reproductive BioMedicine Online

Volumn 21, Issue 4, 2010, Pages 440-443

  Gleicher, Norbert ^a,b   Barad, David H ^a,c  

^a Foundation for Reproductive Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

best available evidence; randomized controlled trial; study design

Indexed keywords

EVIDENCE BASED MEDICINE; FERTILIZATION IN VITRO; GOLD STANDARD; HUMAN; MEDICAL CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTION; REVIEW;

EID: 78650518595     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.06.042     Document Type: Note

References (29)

1. H. Barad, H. Brill, and N. Gleicher Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function J. Assis. Repro. Genet. 24 2007 629 634
2. J.L. Brozek, E.A. Akl, and P. Alonso-Coello Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions Allergy 64 2009 669 677
3. I. Chalmers Explaining the unbiased creation of treatment comparison groups Lancet 374 2009 1670 1671
4. Chambers, D., Fayter, D., Paton, F., Woolacott, N., 2009. Use of non-randomised evidence alongside randomized trials in a systematic review of endovascular aneurism repair: strength and limitations. Eur. J. Vasc. Endovasc. Surg. (Epub ahead of print).
5. J. Cohen, D. Wells, and S. Munné Removal of 2 cells from cleavage stage embryos is likely to reduce efficacy of chromosomal tests that are used to enhance implantation rates Fertil. Steril. 87 2007 496 503
6. L.M. Collins, B. Chakraborty, S.A. Murphy, and V. Strecher Comparison of a phased experimental approach and a single randomized clinical trial for developing multicomponent behavioral interventions Clin. Trials 6 2009 5 15
7. P.J. Deveraux, P.T. Choi, and S. El-Dika An observational study found that authors randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods J. Clin. Epidemiol. 57 2004 1232 1236
8. M. Diomidus Epidemiological study designs Stud. Health Technol. Inform. 65 2002 126 351
9. N. Gleicher Safety in assisted reproduction technology. A rebuttal Hum. Reprod. 18 2003 1765 1766
10. N. Gleicher Patients are entitled to maximal IVF pregnancy rates Reprod. Biomed. Online 18 2009 599 602
11. N. Gleicher, A. Weghofer, and D. Barad Preimplantation genetic screening: 'established' and ready for prime time? Fertil. Steril. 89 2008 780 788
12. M.T. Haahr, and A. Hróbjartsson Who is blinded in randomized clinical trials? A study of 200 trials and surveys of authors Clin. Trials 3 2006 360 365
13. J. Homberger, and E. Wrone When to base clinical policies on observational versus randomized trial data Ann. Intern. Med. 127 1997 697 703
14. S.D. Horn, and J. Gassaway Practice-based evidence study design for comparative effectiveness research Med. Care 45 10 Suppl. 2 2007 S50 S57
15. S.D. Horn, G. DeJong, D.K. Ryser, P.J. Veazie, and J. Teraoka Another look at observational studies in rehabilitation research going beyond the holy grail of the randomized controlled trial Arch. Phys. Med. Rehab. 86 12 Suppl. 2 2005 S8 S15
16. S. Lewin, C. Glenton, and A.D. Oxman Use of qualitative methods alongside randomized controlled trials of complex health care interventions: methodological study BMJ 339 2009 b3496
17. E. Loewy Ethics and evidence-based medicine: is there a conflict? Med. Gen. Med. 9 2007 30
18. S. Mastenbroek, M. Twisk, and J. van Echten-Arends In vitro fertilization with preimplantation genetic screening N. Engl. J. Med. 357 2007 9 17
19. R.L. Prentice, J.E. Manson, and R.D. Langer Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause Am. J. Epidemiol. 170 2009 12 23
20. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestion in healthy postmenopausal women: principle results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
21. L. Rubinstein, J. Crowley, P. Ivy, M. Leblanc, and D. Sergent Randomized phase II designs Clin. Cancer Res. 15 2009 1883 1890
22. J.R. Scott In defense of case reports Obstet. Gynecol. 114 2009 413 414
23. J.R. Scott Evidence-based medicine under attack Obstet. Gynecol. 113 2009 1202 1203
24. G.C.S. Smith, and P. Pell Hazardous journey. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomized controlled trials BMJ 327 2003 1450 1461
25. C. Staessen, P. Platteau, and E. van Assche Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial Hum. Reprod. 19 2004 2849 2858
26. M.J. Stampfer, W.C. Willet, G.A. Colditz, B. Rosner, F.E. Speizer, and C.H. Hennekens A prospective study of postmenopausal estrogen therapy and coronary heart disease N. Engl. J. Med. 313 1985 1044 1049
27. The Committee and of the American Society for Reproductive Medicine Definition of 'experimental procedure' Fertil. Steril. 92 2009 1517
28. A.M. Vintzileos Evidence-based compared with reality-based medicine in obstetrics Obstet. Gynecol. 113 2009 1335 1340
29. P.W. Wilson, R.J. Garrison, and W.P. Castelli Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham study N. Engl. J. Med. 312 1985 1038 1043